An estimated 2.75 million Americans suffer from CHS each year. Learn more about this growing issue and its impact in the latest JAMA report.

View this email in your browser ([link removed])
[link removed]
[link removed]

Your source for the latest news in drug policy. Visit our website ([link removed]) for more news.

This is The Drug Report’s ([link removed]) Friday Fact report - 2.75 Million Americans Suffer from Cannabinoid Hyperemesis Syndrome (CHS) Every Year
[link removed]

On October 10, the Journal of the American Medical Association (JAMA) published a patient education page titled, “Cannabis Hyperemesis Syndrome ([link removed]) .” Cannabinoid Hyperemesis Syndrome (CHS) is characterized by repeated nausea, vomiting, and severe stomach pain after using high doses of tetrahydrocannabinol (THC) over an extended period of time––THC is the psychoactive component of marijuana that makes a user feel “high.” The article explained, “although the exact number of people with CHS is unknown, based on emergency department surveys, CHS is estimated to affect about 2.75 million people in the US yearly.”


The JAMA page continued, “From 2017 to 2021, emergency department visits for CHS doubled in the US and Canada and were most common among males aged 16 to 34 years.”


The New York Times ([link removed]) published an article about personal stories related to the harms of marijuana use. One story was from an actor, David Krumholtz, who was one of many who experienced the effects of CHS. After starting to use marijuana again in 2016, David experienced cycles of severe nausea and vomiting, went to the emergency department multiple times, lost over 100 pounds, and would spend 10 hours in a hot bath to try and relieve the symptoms of his condition. He eventually quit marijuana for good and became better. “It seems like such an innocent drug,” Krumholts said, “but for some of us, there is a real danger, a really harmful side effect.”

The patient education page also added that “the rise in CHS coincides with legalization of recreational cannabis and increases in delta-9-tetrahydrocannabinol (THC) concentration in cannabis products.” This trend will likely worsen as the marijuana industry produces and pushes ever-stronger products.

Received this email from a friend? Sign up here! ([link removed])
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]

Smart Approaches to Marijuana (SAM) ([link removed]) is an alliance of organizations and individuals dedicated to a health-first approach to marijuana policy. We are professionals working in mental health and public health. We are bipartisan. We are medical doctors, lawmakers, treatment providers, preventionists, teachers, law enforcement officers and others who seek a middle road between incarceration and legalization. Our commonsense, third-way approach to marijuana policy is based on reputable science and sound principles of public health and safety.

Copyright (C) 2024 Smart Approaches to Marijuana (SAM). All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
Smart Approaches to Marijuana (SAM)
107 S West St. Ste. 757
Alexandria, VA 22314
USA
Want to change how you receive these emails?
You can update your preferences ([link removed]) or unsubscribe ([link removed])

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Smart Approaches to Marijuana (SAM) . 107 S West St. Ste. 757 . Alexandria, VA 22314 . USA